Interview with Günter Cseh, General Manager, Meda Pharma Austria
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there…
Address: Guglgasse 15/II. Stock, 1110 Vienna,Austria
Tel: +43 + (1) 86390-0
Web: http://www.meda.at/content/home/index.php
Meda is a leading specialty pharmaceutical company in Europe that offers cost-oriented medicine and the medical need. With offices in 26 countries Meda covers almost the whole of Europe. In other world markets, the pharmaceuticals are marketed by Meda and other representatives of pharmaceutical companies and sold.
Meda focuses on the treatment areas asthma & allergies, cardiovascular disease, pain and inflammation, gastroenterology and dermatology & infections.
Meda Pharma GmbH with its headquarters in Vienna (see photo) is a subsidiary of Meda AB., Sweden. Meda Pharma Austria looks back on a long company history, what with the PANCHEMIE HOMBURG found its founding. Subsequently developed into ASTA MEDICA Arzneimittel GmbH, which was renamed in 2002 in VIATRIS Pharma GmbH and since October 2005, owned by the Swedish pharmaceutical company Meda is.
Meda Pharma GmbH Austria continues its focus on products for the therapy and treatment of respiratory diseases (Novolizer ®, Allergodil ®), pain (Adamon ®) for the prevention and treatment of osteoporosis (Maxi-Kalz ®), treatment of cardiovascular disease (Magnosolv ®, Aquaphoril ®) and a specific complication of diabetes mellitus (Thioctacid ®), as well as therapeutic agents for use in the Department of Gynecology (Cyklokapron ® Ftbl., Estrogel ®, Utrogestan ®, Parlodel ®). Another therapeutic area of Meda Pharma, the treatment of skin diseases, such as the actinic keratoses, basal cell carcinomas or genital warts (Aldara ®). The innovative nutritional supplements Longeva ® completes the product range.
Furthermore, there are good pharmacy products such as Ce-soda ®, Histaxin ®, and Kamillosan Travelgum ® and the dietary supplement Osteo-Active ® and Magnofit ® – pellets in the product portfolio of Meda Austria.
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there…
Dr. Nikitsch, you started Menarini’s Austrian operations almost 13 years ago. Would you say that Menarini’s presence in Austria today reflects the vision you had for the company in Austria…
Can you give our readers a snapshot of Austroplant’s scope of activities and its structure in Austria and the central European market? Austroplant/Dr Peithner belongs to the Schwabe Group, the…
Dr Prchla, you have been heading Merck’s Austrian subsidiary over the past eighteen months. What do you see as the key strengths of your company today? Mirroring the company’s structure,…
Just like other European countries, Austria is in the search for meaningful savings in healthcare. Austria’s increasingly price sensitive pharma market is seeing the rise of generic medicines gaining market…
Whereas most General Managers are exposed to different countries during their professional career, you have chosen to dedicate yours to the Austrian market. What is it in this country so…
You have been General Secretary of PHARMIG since 2004 and have witnessed the market’s development over the past 8 years. What have been the most important changes since you started…
See our Cookie Privacy Policy Here
